1. The WTO medicines decision: world pharmaceutical trade and the protection of public health;Abbott;Am. J. Int. Law,2005
2. ACT-A Civil Society And Community Representatives, 2021. Macro changes to the ACT-A: a briefing by the ACT-A civil society and community Representatives. https://covid19advocacy.org/more-transparency-accountability-and-inclusion-needed-in-act-a-letter-to-act-a-leadership-and-brief-from-cs-and-community-representatives/. (Accessed 25 October 2022).
3. Ethnic, racial and regional inequalities in access to COVID-19 vaccine, testing and hospitalization: implications for eradication of the pandemic;Ahlberg;Frontiers in Sociology,2022
4. A global intellectual property waiver is still needed to address the inequities of COVID-19 and future pandemic preparedness;Amin;Inquiry: The Journal of Health Care Organization, Provision, and Financing,2022